Rights and permissions
About this article
Cite this article
Adalimumab to be fully funded in NZ. Pharmacoecon. Outcomes News 493, 18 (2005). https://doi.org/10.2165/00151234-200504930-00050
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504930-00050